# Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)

> **NCT00365443** · PHASE2 · WITHDRAWN · sponsor: **Merck Sharp & Dohme LLC**

## Conditions studied

- Cervical Cancer
- Condylomata Acuminata

## Interventions

- **BIOLOGICAL:** V502

## Key facts

- **NCT ID:** NCT00365443
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00365443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00365443, "Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00365443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*